Tradition Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-72,500
Closed -$536 538
2025
Q4
$536 Hold
72,500
﹤0.01% 497
2025
Q3
$19.8K Hold
72,500
﹤0.01% 487
2025
Q2
$55.4K Buy
72,500
+22,500
+45% +$525K ﹤0.01% 450
2025
Q1
$41.3K Hold
50,000
﹤0.01% 428
2024
Q4
$42.8K Buy
+50,000
New +$1.36M ﹤0.01% 411

Other funds holding PFE

Tradition Wealth Management's PFE Position: Q1 2026 in Review

Tradition Wealth Management increased its Pfizer (PFE) stake by 4.7% in Q1 2026, buying an estimated $14.5K and bringing the position to 12,122 shares worth $340K. The position accounts for 0.02% of the portfolio, ranked #362.

Tradition Wealth Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $877K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Tradition Wealth Management held 12,122 shares of Pfizer worth $340K as of Q1 2026.
  • Tradition Wealth Management bought 544 Pfizer shares in Q1 2026, an estimated $14.5K.
  • Pfizer made up 0.02% of Tradition Wealth Management's portfolio in Q1 2026, its #362 holding.
  • Tradition Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Tradition Wealth Management's Pfizer position peaked at $877K in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Tradition Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.